CB
CRL icon

Cooke & Bieler’s Charles River Laboratories CRL Stock Holding History

Cooke & Bieler’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$171M Sell
755,630
-112,290
-13% -$20M 1.98% 13
2026
Q1 		$150M Buy
867,920
+260,355
+43% +$48.3M 1.69% 14
2025
Q4 		$121M Buy
607,565
+3,688
+0.6% +$669K 1.26% 31
2025
Q3 		$94.5M Buy
603,877
+5,100
+0.9% +$810K 0.98% 45
2025
Q2 		$90.9M Buy
598,777
+179,140
+43% +$23.9M 0.91% 48
2025
Q1 		$63.2M Sell
419,637
-7,130
-2% -$1.2M 0.63% 57
2024
Q4 		$78.8M Buy
426,767
+126,372
+42% +$24.3M 0.76% 51
2024
Q3 		$59.2M Buy
+300,395
New +$62.4M 0.54% 65

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Cooke & Bieler's CRL Position: Q2 2026 in Review

Cooke & Bieler reduced its Charles River Laboratories (CRL) stake by 13% in Q2 2026, selling an estimated $20M and leaving 755,630 shares worth $171M. The position accounts for 1.98% of the portfolio, ranked #13.

Cooke & Bieler first reported a position in CRL in Q3 2024 and has held it in 8 quarters since. 568 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Cooke & Bieler held 755,630 shares of Charles River Laboratories worth $171M as of Q2 2026.
  • Cooke & Bieler sold 112,290 Charles River Laboratories shares in Q2 2026, an estimated $20M.
  • Charles River Laboratories made up 1.98% of Cooke & Bieler's portfolio in Q2 2026, its #13 holding.
  • Cooke & Bieler first reported a position in Charles River Laboratories in Q3 2024 and has held it in 8 quarters since.
  • 568 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Cooke & Bieler's 13F filing for Q2 2026, filed 30 Jul 2026.